VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
RCUS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
RCUSArcus Biosciences, Inc.
$15.76$2.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksRCUSQuarterly Financials

Arcus Biosciences, Inc. (RCUS) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Arcus Biosciences, Inc. (RCUS) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

RCUS Income Statement

Quarterly statement

RCUS Income Statement

Arcus Biosciences, Inc. (RCUS) annual income statement — 10-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue9M41M17M33M26M160M28M26M48M39M145M31M32M29M25M33.66M33M27M18M354.5M
Revenue Growth %-65.38%-74.38%-39.29%26.92%-45.83%310.26%-80.69%-16.13%50%34.48%480%-7.89%-3.03%7.41%38.89%-90.51%248.8%185.38%90.25%3636.68%
Cost of Goods Sold002M3M2M000000000000000
COGS % of Revenue--11.76%9.09%7.69%---------------
Gross Profit9M41M15M30M24M160M28M26M48M39M145M31M32M29M25M33.66M33M27M18M354.5M
Gross Margin %100%100%88.24%90.91%92.31%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %-62.5%-74.38%-46.43%15.38%-50%310.26%-80.69%-16.13%50%34.48%480%-7.89%-3.03%7.41%38.89%-90.51%248.8%185.38%90.25%3636.68%
Operating Expenses140M137M149M144M166M168M150M129M153M145M161M122M112M112M111M108.1M103M96M85M73.23M
OpEx % of Revenue1555.56%334.15%876.47%436.36%638.46%105%535.71%496.15%318.75%371.79%111.03%393.55%350%386.21%444%321.19%312.12%355.56%472.22%20.66%
Selling, General & Admin23M24M29M26M27M29M28M28M30M30M32M29M30M28M30M27.9M26M26M24M23.3M
SG&A % of Revenue255.56%58.54%170.59%78.79%103.85%18.13%100%107.69%62.5%76.92%22.07%93.55%93.75%96.55%120%82.89%78.79%96.3%133.33%6.57%
Research & Development117M113M122M121M141M139M122M101M123M115M109M93M82M84M81M80.2M77M70M61M49.94M
R&D % of Revenue1300%275.61%717.65%366.67%542.31%86.88%435.71%388.46%256.25%294.87%75.17%300%256.25%289.66%324%238.3%233.33%259.26%338.89%14.09%
Other Operating Expenses00-1000K-1000K-1000K000001000K000000000
Operating Income-131M-96M-134M-114M-142M-8M-122M-103M-105M-106M-16M-91M-80M-83M-86M-74.44M-70M-69M-67M281.27M
Operating Margin %-1455.56%-234.15%-788.24%-345.45%-546.15%-5%-435.71%-396.15%-218.75%-271.79%-11.03%-293.55%-250%-286.21%-344%-221.19%-212.12%-255.56%-372.22%79.34%
Operating Income Growth %7.75%-1100%-9.84%-10.68%-35.24%92.45%-662.5%-13.19%-31.25%-27.71%81.4%-22.24%-14.29%-20.29%-28.36%-126.47%10.41%9.37%7.9%640.77%
EBITDA-129M-93M-132M-111M-140M-6M-119M-100M-103M-104M-13M-88M-79M-81M-84M-72.96M-68M-67M-66M280.83M
EBITDA Margin %-1433.33%-226.83%-776.47%-336.36%-538.46%-3.75%-425%-384.62%-214.58%-266.67%-8.97%-283.87%-246.88%-279.31%-336%-216.8%-206.06%-248.15%-366.67%79.22%
EBITDA Growth %7.86%-1450%-10.92%-11%-35.92%94.23%-815.38%-13.64%-30.38%-28.4%84.52%-20.61%-16.18%-20.9%-27.27%-125.98%11.89%11.04%8.27%659.5%
D&A (Non-Cash Add-back)2M3M2M3M2M2M3M3M2M2M3M3M1M2M2M1.48M2M2M1M-441K
EBIT-125M-88M-125M-84M-132M2M-111M-92M-91M-93M-3M-80M-68M-74M-77M-66.9M-65M-66M-67M281.92M
Net Interest Income3M5M6M17M7M8M10M10M13M13M12M11M11M9M8M6.98M5M2M0-260K
Interest Income6M8M9M31M10M10M11M12M14M13M13M11M12M9M9M7.54M5M3M00
Interest Expense3M3M3M14M3M2M1M2M1M01M01M01M563K01M0260K
Other Income/Expense3M5M6M16M7M010M9M13M13M12M11M11M9M8M6.98M5M2M0-84K
Pretax Income-128M-91M-128M-98M-135M-8M-112M-94M-92M-93M-4M-80M-69M-74M-78M-67.46M-65M-67M-67M281.18M
Pretax Margin %-1422.22%-221.95%-752.94%-296.97%-519.23%-5%-400%-361.54%-191.67%-238.46%-2.76%-258.06%-215.63%-255.17%-312%-200.45%-196.97%-248.15%-372.22%79.32%
Income Tax00000001M0001M2M1M2M-4K001M1.81M
Effective Tax Rate %0%0%0%0%0%0%0%-1.06%0%0%0%-1.25%-2.9%-1.35%-2.56%0.01%0%0%-1.49%0.65%
Net Income-128M-91M-128M-98M-135M-8M-112M-94M-92M-93M-4M-81M-71M-75M-80M-67.46M-65M-67M-68M279.37M
Net Margin %-1422.22%-221.95%-752.94%-296.97%-519.23%-5%-400%-361.54%-191.67%-238.46%-2.76%-261.29%-221.88%-258.62%-320%-200.43%-196.97%-248.15%-377.78%78.81%
Net Income Growth %5.19%-1037.5%-14.29%-4.26%-46.74%91.4%-2700%-16.05%-29.58%-24%95%-20.08%-9.23%-11.94%-17.65%-124.15%16.64%11.81%6.33%638.77%
Net Income (Continuing)-128M-91M-128M-98M-135M-8M-112M-95M-92M-93M-4M-81M-71M-75M-80M-67.46M-65M-67M-68M279.37M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.00-0.72-1.02-0.92-1.27-0.08-1.14-1.03-1.01-1.02-0.05-1.08-0.95-1.02-1.10-0.92-0.84-0.90-0.963.71
EPS Growth %21.26%-800%10.53%10.68%-25.74%92.16%-2356.9%4.63%-6.32%0%95.78%-17.39%-13.1%-13.33%-14.58%-124.8%24.32%17.43%11.11%552.44%
EPS (Basic)-1.00-0.72-1.02-0.92-1.27-0.08-1.14-1.03-1.01-1.02-0.05-1.08-0.95-1.02-1.10-0.92-0.84-0.90-0.963.97
Diluted Shares Outstanding127.4M126.1M125.4M107.4M106.5M106.5M98.4M91.7M91.4M91.1M86.2M75M74.6M73.2M73M72.6M72.24M71.81M71.19M75.36M
Basic Shares Outstanding127.4M126.1M125.4M107.4M106.5M106.1M98.4M91.7M91.4M91.1M86.2M75M74.6M73.2M73M72.6M72.2M71.8M71.19M70.4M
Dividend Payout Ratio--------------------